Sight Sciences shares are trading lower after Morgan Stanley maintained an Equal-Weight rating on the stock but lowered its price target from $4 to $3.
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has maintained an Equal-Weight rating on Sight Sciences' stock but has lowered its price target from $4 to $3. This has led to a decrease in the trading price of Sight Sciences' shares.
November 09, 2023 | 7:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley's lowered price target for Sight Sciences from $4 to $3 has negatively impacted the company's share price.
Morgan Stanley's decision to lower the price target for Sight Sciences' stock from $4 to $3 indicates a less optimistic outlook for the company's stock, which can lead to a decrease in the stock's price as investors adjust their expectations. This is reflected in the drop in the trading price of Sight Sciences' shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100